Evidence Hub

High Sensitivity In-Vivo 225Ac Imaging of Mice with a Compton Camera

J. Caravaca, B. Das, A. Bidkar, S. Naik, V. Negut, D. Goodman, M. Streicher, Y. Seo et al.

2025 IEEE Nuclear Science Symposium (NSS), Medical Imaging Conference (MIC) and Room Temperature Semiconductor Detector Conference (RTSD), 2025

Abstract

Targeted alpha therapy with 225Ac is a promising modality for cancer treatment, as recently shown in pre-clinical and clinical trials. Achieving a precise understanding of the biokinetics of 225Ac radiopharmaceuticals is critical to leverage their potential in the clinic. Although this is typically achieved via gamma-ray imaging experiments, such imaging is very challenging for 225Ac due to the extremely low injected activities (<37 kBq), the unfavorable gamma-ray branching ratios (<26%), and the complicated decay chain. Standard SPECT with collimation struggles to achieve quality images and accurate quantification in pre-clinical experiments. In this work, we propose Compton imaging as an alternative solution for this problem. We leverage a commercial CZT Compton camera to achieve in-vivo imaging of 225Ac in mice at therapeutic activities below the microcurie. We compared the sensitivity of a single-head Compton imaging system with that of a standard collimated gamma camera to be 4.7 times greater for 213Bi and 7.5 for 221Fr. We successfully imaged 225Ac daughter biodistributions of 221Fr and 213Bi in a mouse in vivo with only 30 minutes scan time and a single bed position. Performance can be further improved by using more detector heads and via system optimization. Comparison between in-vivo and ex-vivo will be presented and discussed.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free